Evaluating the mucolytic effectiveness of Ambroxol and N-Acetylcysteine in patients with Acute exacerbation of chronic obstructive pulmonary disease

Introduction: Chronic obstructive pulmonary disease (COPD) is the third most fatal disease globally. Acute deterioration of the patient's respiratory symptoms is known as an acute exacerbation of COPD (AECOPD), that goes beyond usual variations and result in change in medications. Ambroxol (ABX) and...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Aswin A. Anil, Devendu Rajesh, Aishwarya Laxmi Krishnan, Ciciliya Arun, Rosemary Thomas, Prashant Chandra, Nithya Haridas
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2024-11-01
Rangatū:	Clinical Epidemiology and Global Health
Ngā marau:	AECOPD Ambroxol N-acetylcysteine Lung function Quality of life
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2213398424002860
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!